Comparative study of efficacy of Pathyadi Churna with Trikatu Churna in the management of Amavata (Rheumatoid Arthritis) wsr to concept of Ama

il0 个研究点目标入组 0 人开始时间: 待定最近更新: 2022年10月17日

试验速览

暂无简介。

•1. Patients of age group 18 to 65 years irrespective of sex
•2. Patients diagnosed with Rheumatoid arthritis (as per predefined ACR 2010 criteria)
•3. Patients with Sama condition (sign & symptoms) of the disease (Amavata)
•4. Patients willing to give written informed consent and willing to participate for a period of six weeks as per the protocol requirements

•1. Patients with complications of Rheumatoid Arthritis such as widespread inflammation, joint damage, cardio-vascular involvement etc
•2. Patients who are unable to walk without support, or are confined to wheel chair or unable to participate in the study assessments due to impaired mobility.
•3. Patients with poorly controlled Hypertension (Ã¢â?°Â¥160/100 mmHg) or Diabetes Mellitus
•{HbA1C >8%).
•4. Patients diagnosed with other types of arthritis like septic arthritis, gout, psoriatic arthritis, Rieters disease etc.
•5. Patients on prolonged ( > 6 weeks) medication with corticosteroids, antidepressants, anticholinergics etc. or any other drugs that may have an influence on the outcome of the study.
•6. Patients with unstable cardio-vascular disease.
•7.Those with a history or presence of hepatic, renal, endocrine, neurological or pulmonary illness that in the opinion of the investigator may influence the study outcomes
•8. Current use or history of use of alcohol or drugs or other habit forming substances such as smoking in the past 6 months
•9.H/o hypersensitivity to any of the ingredients of the trial interventions
•10.Pregnant women and lactating women.

发起方